litlas
Log inCreate account

Judy E. Garber

Active 1988–2026

Also published as
Judy E Garber
252
Papers
63,169
Citations
130
h-index
247
i10-index

Citations

Citations per year for Judy E. Garber1945: 2 citations1971: 1 citations1982: 1 citations1985: 2 citations1987: 1 citations1989: 1 citations1991: 3 citations1992: 6 citations1993: 24 citations1994: 72 citations1995: 106 citations1996: 128 citations1997: 195 citations1998: 129 citations1999: 125 citations2000: 182 citations2001: 205 citations2002: 263 citations2003: 191 citations2004: 236 citations2005: 247 citations2006: 249 citations2007: 269 citations2008: 301 citations2009: 322 citations2010: 485 citations2011: 428 citations2012: 408 citations2013: 447 citations2014: 524 citations2015: 520 citations2016: 612 citations2017: 681 citations2018: 630 citations2019: 1,904 citations2020: 1,956 citations2021: 1,946 citations2022: 1,538 citations2023: 1,120 citations2024: 1,807 citations2025: 752 citations2026: 23 citations1946–1970: no citations, so these years are not shown1972–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1986: no citations, so this year is not shown1988: no citations, so this year is not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,161 citing papers, 28.1% of this breakdownUnited Kingdom: 1,994 citing papers, 7.8% of this breakdownChina: 1,614 citing papers, 6.3% of this breakdownCanada: 1,216 citing papers, 4.8% of this breakdownItaly: 1,166 citing papers, 4.6% of this breakdownGermany: 1,062 citing papers, 4.2% of this breakdownFrance: 902 citing papers, 3.5% of this breakdownAustralia: 879 citing papers, 3.5% of this breakdownNetherlands: 828 citing papers, 3.2% of this breakdownSpain: 725 citing papers, 2.8% of this breakdownJapan: 530 citing papers, 2.1% of this breakdownSweden: 485 citing papers, 1.9% of this breakdown
0%28.1%Other 27.2%

Institutions

Fields

  • Medicine47.5%
  • Biochemistry, Genetics and Molecular Biology46.2%
  • Immunology and Microbiology1.7%
  • Computer Science1%
  • Psychology0.8%
  • Engineering0.5%
  • Other2.3%

Topics

  • BRCA gene mutations in cancer7.8%
  • Cancer Genomics and Diagnostics6%
  • Genetic factors in colorectal cancer4.6%
  • DNA Repair Mechanisms4.4%
  • PARP inhibition in cancer therapy4.3%
  • Breast Cancer Treatment Studies4.1%
  • Other68.8%

Coauthors

All papers

Open in search
  1. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    Authors: Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 cited by 1,665

  2. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    Authors: Harold J. Burstein, Giuseppe Curigliano, Beat Thürlimann, William P. Weber, Philip Poortmans, Meredith M. Regan, H.-J. Senn, Eric P. Winer, Michael Gnant, Stephan Aebi, Fabrice André, Carlos Barrios, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel Morales, Sara Y. Brucker, Harold J. Burstein, David Cameron, Fátima Cardoso, Lisa A. Carey, Boon Chua, Eva Ciruelos, Marco Colleoni, Giuseppe Curigliano, Suzette Delaloge, Carsten Denkert, Peter Dubsky, Bent Ejlertsen, Florian Fitzal, Prudence A. Francis, Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 cited by 803

  3. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Authors: Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross, Priya Rastogi, Karen Cui, Amal Arahmani, Gursel Aktan, Anne Armstrong, Mónica Arnedos, Judith Balmaña, Jonas Bergh, Judith M. Bliss, Suzette Delaloge, Susan M. Domchek, Andrea Eisen, F. Elsafy, L.E. Fein, Anitra Fielding, James M. Ford, Sue Friedman, Karen A. Gelmon, Luca Gianni, Michael Gnant, Simon J. Hollingsworth, Seock‐Ah Im, Agnes Jager, Oskar T. Johannsson, Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke and 509 more - Annals of Oncology 2022 cited by 447

  4. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

    Authors: Melinda L. Telli, Kirsten M. Timms, Julia Reid, Bryan T. Hennessy, Gordon B. Mills, Kristin C. Jensen, Zoltán Szállási, William T. Barry, Eric P. Winer, Nadine Tung, Steven J. Isakoff, Paula D. Ryan, April Greene-Colozzi, Alexander Gutin, Zaina Sangale, Diana Iliev, Chris Neff, Victor Abkevich, Joshua T. Jones, Jerry S. Lanchbury, Anne‐Renee Hartman, Judy E. Garber, James M. Ford, Daniel P. Silver, Andrea L. Richardson - Clinical Cancer Research 2016 cited by 1,163

  5. Mutational Processes Molding the Genomes of 21 Breast Cancers

    Authors: Serena Nik‐Zainal, Ludmil B. Alexandrov, David C. Wedge, Peter Van Loo, Christopher Greenman, Keiran Raine, David Jones, Jonathan Hinton, John Marshall, Lucy Stebbings, Andrew Menzies, Sancha Martin, Kenric Leung, Lina Chen, Catherine Leroy, Manasa Ramakrishna, Richard Rance, King Wai Lau, Laura Mudie, Ignacio Varela, David J. McBride, Graham R. Bignell, Susanna L. Cooke, Adam Shlien, John Gamble, Ian Whitmore, Mark Maddison, Patrick Tarpey, Helen Davies, Elli Papaemmanuil, Philip J. Stephens, Stuart McLaren, Adam P. Butler, Jon W. Teague, Göran Jönsson, Judy E. Garber, Daniel P. Silver, Penelope Miron, Aquila Fatima, Sandrine Boyault, Anita Langerød, Andrew Tutt, John W.M. Martens, Samuel Aparício, Åke Borg, Anne Vincent Salomon, Gilles Thomas, Anne‐Lise Børresen‐Dale, Andrea L. Richardson, Michael S. Neuberger, P. Andrew Futreal, Peter J. Campbell, Michael R. Stratton - Cell 2012 cited by 2,023

  6. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Authors: Haoyu Zhang, Thomas U. Ahearn, Julie Lecarpentier, Daniel R. Barnes, Jonathan Beesley, Guanghao Qi, Xia Jiang, Tracy A. O’Mara, Ni Zhao, Manjeet K. Bolla, Alison M. Dunning, Joe Dennis, Qin Wang, Zumuruda Abu Ful, Kristiina Aittomäki, Irene L. Andrulis, Hoda Anton‐Culver, Volker Arndt, Kristan J. Aronson, Banu Arun, Paul L. Auer, Jacopo Azzollini, Daniel Barrowdale, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Javier Benı́tez, Marina Bermisheva, Katarzyna Białkowska, Ana Blanco, Carl Blomqvist, Natalia Bogdanova, Stig E. Bojesen, Bernardo Bonanni, Davide Bondavalli, Åke Borg, Hiltrud Brauch, Hermann Brenner, Ignacio Briceño, Annegien Broeks, Sara Y. Brucker, Thomas Brüning, Barbara Burwinkel, Saundra S. Buys, Helen Byers, Trinidad Caldés, Maria A. Caligo, Mariarosaria Calvello, Daniele Campa, Jose E. Castelao, Jenny Chang‐Claude, Stephen J. Chanock, Melissa Christiaens, Hans Christiansen, Wendy K. Chung, Kathleen Claes, Christine L. Clarke, Sten Cornelissen, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Peter Devilee, Orland Dı́ez, Susan M. Domchek, Thilo Dörk, Miriam Dwek, Diana M. Eccles, Arif B. Ekici, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Lenka Foretová, Florentia Fostira, Eitan Friedman, Debra Frost, Manuela Gago-Domínguez, Susan M. Gapstur, Judy E. Garber, José Á. García-Sáenz, Mia M. Gaudet, Simon A. Gayther, Graham G. Giles, Andrew K. Godwin, Mark S. Goldberg, David E. Goldgar, Anna González‐Neira, Mark H. Greene, Jacek Gronwald, Pascal Guénel, Lothar Häberle, Eric Hahnen, Christopher A. Haiman, Christopher R. Hake, Per Hall, Ute Hamann, Elaine F. Harkness, Bernadette A. M. Heemskerk‐Gerritsen, Peter Hillemanns and 176 more - Nature Genetics 2020 cited by 567

  7. Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents

    Authors: Nicolai J. Birkbak, Zhigang C. Wang, Ji-Young Kim, Aron C. Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J. Dirk Iglehart, Nadine Tung, Paula D. Ryan, Judy E. Garber, Daniel P. Silver, Zoltán Szállási, Andrea L. Richardson - Cancer Discovery 2012 cited by 689

  8. TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

    Authors: Nadine Tung, Mark E. Robson, Steffen Ventz, Cesar A. Santa‐Maria, Rita Nanda, P. Kelly Marcom, Payal D. Shah, Tarah J. Ballinger, Eddy S. Yang, Shaveta Vinayak, Michelle Melisko, Adam Brufsky, Michelle K. DeMeo, C. David Jenkins, Susan M. Domchek, Alan D. D’Andrea, Nancy U. Lin, Melissa E. Hughes, Lisa A. Carey, Nick Wagle, Gerburg M. Wulf, Ian E. Krop, Antonio C. Wolff, Eric P. Winer, Judy E. Garber - Journal of Clinical Oncology 2020 cited by 500

  9. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

    Authors: Anita K. Mehta, Emily Cheney, Christina Hartl, Constantia Pantelidou, Madisson Oliwa, Jessica A. Castrillon, Jia‐Ren Lin, Katie E. Hurst, Mateus de Oliveira Taveira, Nathan Johnson, William M. Oldham, Marian Kalocsay, Matthew J. Berberich, Sarah A. Boswell, Aditi Kothari, Shawn F. Johnson, Deborah Dillon, Mikel Lipschitz, Scott J. Rodig, Sandro Santagata, Judy E. Garber, Nadine Tung, José Yélamos, Jessica E. Thaxton, Elizabeth A. Mittendorf, Peter K. Sorger, Geoffrey I. Shapiro, Jennifer L. Guerriero - Nature Cancer 2020 cited by 259

  10. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    Authors: Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer, Michael Gnant, Peter Dubsky, Sibylle Loibl, Marco Colleoni, Meredith M. Regan, Martine Piccart, Hans-Jörg Senn, Beat Thürlimann, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Sara Y. Brucker, Fátima Cardoso, Lisa A. Carey, Eva Ciruelos, Jack Cuzick, Carsten Denkert, Angelo Di Leo, Bent Ejlertsen, Prudence A. Francis, V.E. Galimberti, Judy E. Garber, Bahadır M. Güllüoğlu, Pamela J. Goodwin, Nadia Harbeck, Daniel F. Hayes, Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 cited by 1,255

  11. Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families

    Authors: Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M. Dunning, James Redman, James A. Scarth, Inga Plaskocinska, Craig Luccarini, Mitul Shah, Karen A. Pooley, Leila Dorling, Andrew Lee, Muriel A. Adank, Julian Adlard, Kristiina Aittomäki, Irene L. Andrulis, Peter Ang, Julian Barwell, Jonine L. Bernstein, Kristie Bobolis, Åke Borg, Carl Blomqvist, Kathleen Claes, Patrick Concannon, Adeline Cuggia, Julie O. Culver, Francesca Damiola, Antoine De Pauw, Orland Dı́ez, Jill S. Dolinsky, Susan M. Domchek, Christoph Engel, D. Gareth Evans, Florentia Fostira, Judy E. Garber, Lisa Golmard, Ellen L. Goode, Stephen B. Gruber, Eric Hahnen, Christopher R. Hake, Tuomas Heikkinen, Judith Hurley, Ramūnas Janavičius, Zdeněk Kleibl, Petra Kleiblová, Irene Konstantopoulou, Anders Kvist, Holly LaDuca, Ann S. G. Lee, Fabienne Lesueur, Eamonn R. Maher, Arto Mannermaa, Siranoush Manoukian, Rachel McFarland, Wendy McKinnon, Alfons Meindl, Kelly Metcalfe, Nur Aishah Mohd Taib, Jukka S. Moilanen, Katherine L. Nathanson, Susan L. Neuhausen, Pei Sze Ng, Tú Nguyen‐Dumont, Sarah M. Nielsen, Florian Obermair, Kenneth Offit, Olufunmilayo I. Olopade, Laura Ottini, Judith Penkert, Katri Pylkäs, Paolo Radice, Susan J. Ramus, Vilius Rudaitis, Lucy Side, Rachel Silva‐Smith, Valentina Silvestri, Anne‐Bine Skytte, Thomas Slavin, Jana Soukupová, Carlo Tondini, Alison H. Trainer, Gary Unzeitig, Lydia Usha, Thomas van Overeem Hansen, James Whitworth, Marie Wood, Cheng Har Yip, Sook‐Yee Yoon, Amal Yussuf, George Zogopoulos, David E. Goldgar, John L. Hopper, Georgia Chenevix‐Trench, Paul D.P. Pharoah, Sophia George, Judith Balmañà, Claude Houdayer and 19 more - Journal of Clinical Oncology 2019 cited by 418

  12. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages

    Authors: Jennifer M. Rosenbluth, Ron C.J. Schackmann, G. Kenneth Gray, Laura M. Selfors, Carman Man-Chung Li, Mackenzie Boedicker, Hendrik J. Kuiken, Andrea L. Richardson, Jane Brock, Judy E. Garber, Deborah Dillon, Norman Sachs, Hans Clevers, Joan S. Brugge - Nature Communications 2020 cited by 273

  13. A human breast atlas integrating single-cell proteomics and transcriptomics

    Authors: G. Kenneth Gray, Carman Man-Chung Li, Jennifer M. Rosenbluth, Laura M. Selfors, Nomeda Girnius, Jia‐Ren Lin, Ron C.J. Schackmann, Walter L. Goh, Kaitlin Moore, Hana Shapiro, Shaolin Mei, Kurt D’Andrea, Katherine L. Nathanson, Peter K. Sorger, Sandro Santagata, Aviv Regev, Judy E. Garber, Deborah Dillon, Joan S. Brugge - Developmental Cell 2022 cited by 163

  14. PARP inhibition in breast cancer: progress made and future hopes

    Authors: Nadine Tung, Judy E. Garber - npj Breast Cancer 2022 cited by 148

  15. Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition

    Authors: Carlos R. Gil Del Alcazar, Sung Jin Huh, Muhammad B. Ekram, Anne Trinh, Lin Liu, Francisco Beça, Xiaoyuan Zi, Minsuk Kwak, Helga Bergholtz, Ying Su, Lina Ding, Hege G. Russnes, Andrea L. Richardson, Kirsten Babski, Elizabeth Min Hui Kim, Charles H. McDonnell, Jon Wagner, Ron Rowberry, Gordon J. Freeman, Deborah Dillon, Thérese Sørlie, Lisa M. Coussens, Judy E. Garber, Rong Fan, Kristie Bobolis, D. Craig Allred, Joon Jeong, So Yeon Park, Franziska Michor, Kornélia Polyák - Cancer Discovery 2017 cited by 242

  16. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

    Authors: Andrew Tutt, Mark E. Robson, Judy E. Garber, Susan M. Domchek, M. William Audeh, Jeffrey N. Weitzel, Michael Friedländer, Banu Arun, Niklas Loman, Rita K. Schmutzler, Andrew Wardley, Gillian Mitchell, Helena Earl, Mark Wickens, James Carmichael - The Lancet 2010 cited by 1,636

  17. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA)

    Authors: Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis, Susan M. Domchek, Diana Eccles, Heli Nevanlinna, Susan J. Ramus, Amanda B. Spurdle, Mark E. Robson, Mark E. Sherman, Anna Marie Mulligan, Fergus J. Couch, Christoph Engel, Lesley McGuffog, Sue Healey, Olga M. Sinilnikova, Melissa C. Southey, Mary Beth Terry, David E. Goldgar, Frances P. O’Malley, Esther M. John, Ramūnas Janavičius, Laima Tihomirova, Thomas van Overeem Hansen, Finn C. Nielsen, Ana Osório, Alexandra Stavropoulou, Javier Benı́tez, Siranoush Manoukian, Bernard Peissel, Monica Barile, Sara Volorio, Barbara Pasini, Riccardo Dolcetti, Anna Laura Putignano, Laura Ottini, Paolo Radice, Ute Hamann, Muhammad Usman Rashid, Frans B.L. Hogervorst, Mieke Kriege, Rob B. van der Luijt, Susan Peock, Debra Frost, D. Gareth Evans, Carole Brewer, Lisa Walker, Mark T. Rogers, Lucy Side, Catherine Houghton, JoEllen Weaver, Andrew K. Godwin, Rita K. Schmutzler, Barbara Wappenschmidt, Alfons Meindl, Karin Kast, Norbert Arnold, Dieter Niederacher, Christian Sutter, Helmut Deißler, Doroteha Gadzicki, Sabine Preisler‐Adams, Raymonda Varon-Mateeva, Ines Schönbuchner, Heidrun Gevensleben, Dominique Stoppa‐Lyonnet, Muriel Belotti, Laure Barjhoux, Claudine Isaacs, Beth N. Peshkin, Trinidad Caldés, Miguel de la Hoya, Carmen Cañadas, Tuomas Heikkinen, Päivi Heikkilä, Kristiina Aittomäki, Ignacio Blanco, Conxi Lázaro, Joan Brunet, Bjarni A. Agnarsson, Aðalgeir Arason, Rósa B. Barkardóttir, Martine Dumont, Jacques Simard, Marco Montagna, Simona Agata, Emma D’Andrea, Max Yan, Stephen B. Fox, Timothy R. Rebbeck, Wendy S. Rubinstein, Nadine Tung, Judy E. Garber, Xianshu Wang, Zachary Fredericksen, V. Shane Pankratz, Noralane M. Lindor, Csilla I. Szabo, Kenneth Offit, Rita A. Sakr and 33 more - Cancer Epidemiology Biomarkers & Prevention 2012 cited by 668

  18. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

    Authors: Christian P. Kratz, Maria Isabel Achatz, Laurence Brugières, Thierry Frébourg, Judy E. Garber, Mary‐Louise C. Greer, Jordan R. Hansford, Katherine A. Janeway, Wendy Kohlmann, Rose B. McGee, Charles G. Mullighan, Kenan Onel, Kristian W. Pajtler, Stefan M. Pfister, Sharon A. Savage, Joshua D. Schiffman, Katherine A. Schneider, Louise C. Strong, D. Gareth Evans, Jonathan D. Wasserman, Anita Villani, David Malkin - Clinical Cancer Research 2017 cited by 521

  19. Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

    Authors: Fergus J. Couch, Steven N. Hart, Priyanka Sharma, Amanda E. Toland, Xianshu Wang, Penelope Miron, Janet E. Olson, Andrew K. Godwin, V. Shane Pankratz, Curtis Olswold, Seth W. Slettedahl, Emily Hallberg, Lucia Guidugli, Jaime Davila, Matthias W. Beckmann, Wolfgang Janni, Brigitte Rack, Arif B. Ekici, Dennis J. Slamon, Irene Konstantopoulou, Florentia Fostira, Athanassios Vratimos, George Fountzilas, Liisa M. Pelttari, William Tapper, Lorraine Durcan, Simon S. Cross, Robert Pilarski, Charles L. Shapiro, Jennifer R. Klemp, Song Yao, Judy E. Garber, Angela Cox, Hiltrud Brauch, Christine B. Ambrosone, Heli Nevanlinna, Drakoulis Yannoukakos, Susan L. Slager, Celine M. Vachon, Diana M. Eccles, Peter A. Fasching - Journal of Clinical Oncology 2014 cited by 684

  20. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

    Authors: Kyle C. Strickland, Brooke E. Howitt, Sachet A. Shukla, Scott J. Rodig, Lauren L. Ritterhouse, Joyce F. Liu, Judy E. Garber, Dipanjan Chowdhury, Catherine J. Wu, Alan D. D’Andrea, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos - Oncotarget 2016 cited by 621

  21. The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome

    Authors: Fabíola Medeiros, Michael G. Muto, Yonghee Lee, Julia A. Elvin, Michael J. Callahan, Colleen M. Feltmate, Judy E. Garber, Daniel W. Cramer, Christopher P. Crum - The American Journal of Surgical Pathology 2006 cited by 919

  22. Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    Authors: Paul E. Goss, James N. Ingle, José E. Alés‐Martínez, Angela M. Cheung, Rowan T. Chlebowski, Jean Wactawski‐Wende, Anne McTiernan, John A. Robbins, Karen Johnson, Lisa W. Martin, Eric Winquist, Gloria E. Sarto, Judy E. Garber, Carol J. Fabian, Pascal Pujol, Elizabeth Maunsell, Patricia Farmer, Karen A. Gelmon, Dongsheng Tu, Harriet Richardson - New England Journal of Medicine 2011 cited by 961

  23. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

    Authors: Therese B. Bevers, Mark A. Helvie, Ermelinda Bonaccio, Kristine E. Calhoun, Mary B. Daly, William B. Farrar, Judy E. Garber, Richard J. Gray, Caprice C. Greenberg, Rachel A. Greenup, Nora Hansen, Randall E. Harris, Alexandra S. Heerdt, Teresa Helsten, Linda Hodgkiss, Tamarya L. Hoyt, John G. Huff, Lisa K. Jacobs, Constance D. Lehman, Barbara Monsees, Bethany L. Niell, Catherine Parker, Mark D. Pearlman, Liane E. Philpotts, Laura B. Shepardson, Mary Lou Smith, Matthew A. Stein, Lusine Tumyan, Cheryl Williams, Mary Anne Bergman, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2018 cited by 519

  24. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set

    Authors: Christian P. Kratz, Claire Freyçon, Kara N. Maxwell, Kim E. Nichols, Joshua D. Schiffman, D. Gareth Evans, Maria Isabel Achatz, Sharon A. Savage, Jeffrey N. Weitzel, Judy E. Garber, Pierre Hainaut, David Malkin - JAMA Oncology 2021 cited by 146